Target intelligence / Profile preview

Clarin-1 (CLRN1)

Target
CLRN1
Molecular classification
Tetraspanin-like membrane protein, Four-transmembrane domain protein, Other
01

Overview

Clarin-1 is a tetraspan-like membrane protein encoded by the CLRN1 gene, which is essential for normal function and development of sensory hair cells in the inner ear and photoreceptor cells in the retina. Clarin-1 contains four predicted transmembrane domains and shares similarity with the tetraspanin family. It is critical for the organization of actin filaments, maintenance of hair cell mechanotransduction apparatus, and proper localization of synaptic machinery. Mutations in CLRN1 cause Usher syndrome type III (USH3A), a rare autosomal recessive disorder characterized by progressive hearing and vision loss. The protein’s precise molecular function is incompletely resolved, but studies indicate central roles in protein complex formation, intracellular signaling, and establishment of specialized membrane domains in sensory cells. While not a drug target or receptor in a conventional therapeutic sense, the gene is important in genetic diagnostics and research efforts related to inherited sensory loss syndromes.

Other names
Usher syndrome type 3 proteinUsher syndrome 3A proteinUSH3A_HUMANUSH3A
02

Biological functions

Regulation and homeostasis of actin filamentsMechanotransduction in sensory hair cellsSynaptic maturation and localization of synaptic componentsNeuronal communication in the inner ear and retina
03

Disease associations

Usher syndrome type III (USH3A): Progressive hearing and vision lossRetinitis pigmentosa (as a presenting symptom)
04

Safety considerations

Loss or dysfunction of clarin-1 leads to progressive hearing impairment and vision loss due to sensory cell defects in the inner ear and retina; no known pharmacological targeting; gene therapy attempted in preclinical modelsGenetic variability may influence therapeutic responsiveness and genetic counseling
05

Biomarkers

Mutations in CLRN1 as a genetic marker for Usher syndrome type III (most notably Tyr176Ter [Y176X/Finmajor] and Met120Lys [M120K/Finminor])

Beyond the preview

Go deeper on Clarin-1 (CLRN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarin-1 (CLRN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call